-
EP3962467
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3962467
| EP3962467 - USE OF CANNABIDIOL IN THE TREATMENT OF TUBEROUS SCLEROSIS COMPLEX [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 19.04.2024 Database last updated on 07.04.2026 | |
| Former | Examination is in progress Status updated on 23.06.2023 | ||
| Former | Request for examination was made Status updated on 04.02.2022 | ||
| Former | The international publication has been made Status updated on 13.11.2020 | ||
| Former | unknown Status updated on 19.05.2020 | Most recent event Tooltip | 19.04.2024 | Application deemed to be withdrawn | published on 22.05.2024 [2024/21] | Applicant(s) | For all designated states GW Research Limited Sovereign House Vision Park Chivers Way Histon Cambridge, Cambridgeshire CB24 9BZ / GB | [2022/10] | Inventor(s) | 01 /
GUY, Geoffrey GW Pharma Limited, Sovereign House, Vision Park Chivers Way, Histon Cambridge Cambridgeshire CB24 9BZ / GB | 02 /
KNAPPERTZ, Volker GW Pharma Limited Sovereign House, Vision Park Chivers Way, Histon Cambridge Cambridgeshire CB24 9BZ / GB | 03 /
DUNAYEVICH, Eduardo Greenwich Biosciences Inc. 5750 Fleet St. Suite 200 Carlsbad, California 92008 / US | 04 /
CHECKETTS, Daniel GW Pharma Limited Sovereign House, Vision Park Chivers Way, Histon Cambridge Cambridgeshire CB24 9BZ / GB | [2022/10] | Representative(s) | HGF HGF Limited 4th Floor, 1 City Square Leeds LS1 2ES / GB | [N/P] |
| Former [2022/10] | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | Application number, filing date | 20724924.4 | 01.05.2020 | [2022/10] | WO2020GB51080 | Priority number, date | GB20190006261 | 03.05.2019 Original published format: GB 201906261 | [2022/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020225540 | Date: | 12.11.2020 | Language: | EN | [2020/46] | Type: | A1 Application with search report | No.: | EP3962467 | Date: | 09.03.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.11.2020 takes the place of the publication of the European patent application. | [2022/10] | Search report(s) | International search report - published on: | EP | 12.11.2020 | Classification | IPC: | A61K31/05, A61K31/19, A61K31/197, A61K31/4015, A61K31/551, A61K45/06, A61P25/08, A61K36/185 | [2022/10] | CPC: |
A61K31/05 (EP,IL,KR);
A61K31/658 (KR,US);
A61K31/352 (GB,KR);
A61K31/19 (EP,IL);
A61K31/197 (EP,IL,KR);
A61K31/4015 (EP,IL,KR);
A61K31/551 (EP,IL,KR);
A61K36/3482 (EP,GB,IL,KR,US);
A61K45/06 (EP,GB,IL,KR);
| C-Set: |
A61K31/05, A61K2300/00 (EP);
A61K31/197, A61K2300/00 (EP);
A61K31/19, A61K2300/00 (EP);
A61K31/4015, A61K2300/00 (EP); | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/10] | Title | German: | VERWENDUNG VON CANNABIDIOL BEI DER BEHANDLUNG EINES TUBERÖSEN SKLEROSEKOMPLEXES | [2022/10] | English: | USE OF CANNABIDIOL IN THE TREATMENT OF TUBEROUS SCLEROSIS COMPLEX | [2022/10] | French: | UTILISATION DE CANNABIDIOL DANS LE TRAITEMENT DE LA SCLÉROSE TUBÉREUSE DE BOURNEVILLE | [2022/10] | Entry into regional phase | 19.11.2021 | National basic fee paid | 19.11.2021 | Designation fee(s) paid | 19.11.2021 | Examination fee paid | Examination procedure | 19.11.2021 | Examination requested [2022/10] | 19.11.2021 | Date on which the examining division has become responsible | 17.06.2022 | Amendment by applicant (claims and/or description) | 22.06.2023 | Despatch of a communication from the examining division (Time limit: M06) | 03.01.2024 | Application deemed to be withdrawn, date of legal effect [2024/21] | 23.01.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2024/21] | Fees paid | Renewal fee | 18.03.2022 | Renewal fee patent year 03 | 28.03.2023 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X] GB2531282 (GW PHARMA LTD et al.) | [XI] EVAN J. HESS ET AL: "Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex", EPILEPSIA, vol. 57, no. 10, 1 October 2016 (2016-10-01), NEW YORK, US, pages 1617 - 1624, XP055501922, ISSN: 0013-9580, DOI: 10.1111/epi.13499 DOI: http://dx.doi.org/10.1111/epi.13499 | [XI] KATHERINE NICKELS: "Cannabidiol in Patients With Intractable Epilepsy Due to TSC: A Possible Medication But Not a Miracle", EPILEPSY CURRENTS, vol. 17, no. 2, 1 March 2017 (2017-03-01), US, pages 91 - 92, XP055501933, ISSN: 1535-7597, DOI: 10.5698/1535-7511.17.2.91 DOI: http://dx.doi.org/10.5698/1535-7511.17.2.91 | by applicant | WO2011001169 | WO2012093255 | WO2013045891 | WO2016059399 | "Handbook of Cannabis, Roger Pertwee", pages: 3 - 15 |